Form 4 for CRL Charles River Laboratories
Accepted 2021-12-27 00:00:00 ET · period of report 2021-11-22 · accession 0001127602-21-031913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-27 | 2021-11-22 | CRL | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -182 | 8,280 | -2% | $0 | ||
| 2021-12-27 | 2021-12-25 | CRL | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +6,771 | 15.1K | +82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-22 | G | D | 182 | $0.00 | 8,280 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-25 | A | A | 6,771 | $0.00 | 15,051 | D | — | — | (F1) Unvested restricted stock units vest as follows: 6,771 on December 25, 2026. |